GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » RxSight Inc (NAS:RXST) » Definitions » 5-Year Yield-on-Cost %

RxSight (RxSight) 5-Year Yield-on-Cost % : 0.00 (As of May. 18, 2024)


View and export this data going back to 2021. Start your Free Trial

What is RxSight 5-Year Yield-on-Cost %?

RxSight's yield on cost for the quarter that ended in Mar. 2024 was 0.00.


The historical rank and industry rank for RxSight's 5-Year Yield-on-Cost % or its related term are showing as below:



RXST's 5-Year Yield-on-Cost % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.25
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of RxSight's 5-Year Yield-on-Cost %

For the Medical Devices subindustry, RxSight's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RxSight's 5-Year Yield-on-Cost % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, RxSight's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where RxSight's 5-Year Yield-on-Cost % falls into.



RxSight 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of RxSight is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

RxSight  (NAS:RXST) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


RxSight 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of RxSight's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


RxSight (RxSight) Business Description

Traded in Other Exchanges
N/A
Address
100 Columbia, Aliso Viejo, CA, USA, 92656
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery.
Executives
Ilya Goldshleger officer: Chief Operating Officer C/O RXSIGHT, INC., 100 COLUMBIA, ALISO VIEJO CA 92656
Eric Weinberg officer: Chief Commercial Officer C/O RXSIGHT, INC., 100 COLUMBIA, ALISO VIEJO CA 92656
Shweta Maniar director C/O SEASPINE HOLDINGS CORP, 5770 ARMADA DRIVE, CARLSBAD CA 92008
Jesse Anderson Corley director C/O RXSIGHT, INC., 100 COLUMBIA, ALISO VIEJO CA 92656
Kurtz Ronald M Md director, officer: See Remarks C/O RXSIGHT, INC., 100 COLUMBIA, ALISO VIEJO CA 92656
Robert Keith Warner director C/O RXSIGHT, INC., 100 COLUMBIA, ALISO VIEJO CA 92656
Shelley B Thunen officer: Chief Financial Officer C/O RXSIGHT, INC., 100 COLUMBIA, ALISO VIEJO CA 92656
Bakker Juliet Tammenoms director LONGITUDE CAPITAL MANAGEMENT CO., LLC, 800 EL CAMINO REAL, SUITE 220, MENLO PARK CA 94025
Tamara Fountain director C/O RXSIGHT, INC., 100 COLUMBIA, ALISO VIEJO CA 92656
Robert J Palmisano director 110 HARTWELL AVENUE, LEXINGTON MA 02173
Link William J Phd director, 10 percent owner ONE SANSOME STREET, SUITE 1650, SAN FRANCISCO CA 94104
Julie Andrews director 5677 AIRLINE ROAD, ARLINGTON TN 38002
Rajeev M. Shah 10 percent owner 200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116
Peter Kolchinsky 10 percent owner 200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116
Ra Capital Management, L.p. 10 percent owner 200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116

RxSight (RxSight) Headlines

From GuruFocus

RxSight, Inc. Announces Pricing of Public Offering of Common Stock

By Stock market mentor Stock market mentor 02-08-2023

RxSight, Inc. Reports First Quarter 2022 Financial Results

By GuruFocusNews GuruFocusNews 06-05-2022

RxSight, Inc. Announces Proposed Public Offering of Common Stock

By Stock market mentor Stock market mentor 02-07-2023

RxSight, Inc. to Present at the Oppenheimer Healthcare Conference

By sperokesalga sperokesalga 02-28-2023

RxSight, Inc. to Present at the Bank of America Healthcare Conference

By sperokesalga sperokesalga 04-26-2023

RxSight, Inc. Reports First Quarter 2022 Financial Results

By GuruFocusNews GuruFocusNews 06-15-2022

Director Shweta Maniar Sells 6,399 Shares of RxSight Inc

By GuruFocus Research 01-19-2024